# Richard Skaife

Episod podcast teratas
Dikemas kini:

#014 Richard Skaife: Reframing recreational psychedelics

Summary: We talk with Richard Skaife — cofounding partner of The Conscious Fund — about new science on recreational psychedelic use, choosing companies to invest in, and personal experiences on MDMA. Richard talks about Elon Musk's take on psychedelics, how some of our greatest minds benefited f ...

Richard Skaife, Founding Partner @ The Conscious Fund | Episode 34 | Podium Stories

Richard is a founding partner of The Conscious Fund, which invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain. Richard has made over 20 investments in psychedelic medicine companies with five of them going from s ...

S03E74 - Richard Skaife - The Future Of Psychedelics

The Mindfulness Experience Podcast welcomes Mr. Richard Skaife, the Co-Founder and Partner of The Conscious Fund, investing in global early-stage ventures in psychedelic medicine. He has made dozens of investments in psychedelic medicine companies and is the Chairman of Microdose and Wonderland, ...

Investing in Psychedelic Medicine: The Future of Mental Health Treatment

Psychedelic medicine is revolutionizing the field of mental health and addiction treatment. After years of stagnant options and limited progress, the emergence of psychedelic medications and therapies offers hope for those who have not found effective treatments through traditional methods. In t ...

Richard Skaife

Richard Skaife is a Partner at The Conscious Fund ( an investor in Microdose and most of the well known companies in the psychedelic medicine space) and a Co Founding Partner at Longr a longevity platform company focused on access. He’s served as a partner in European tier 1 VC funds and as a CE ...

Longevity Is an Operating System, Not a Pill | Richard Skaife

In this episode of the Superhuman Podcast, I sit down with Richard Skaife, a longevity investor working at the intersection of biotech, mental health, and frontier technology. We talk about why longevity isn't a supplement or a shortcut - it's an operating system. We break down healthspan vs li ...

Introducing The Peptide Show

The Peptide Show explores the science, medicine and business of peptides, with the people shaping what comes next. Hosted by Richard Skaife, new episodes arrive every Tuesday. Episode 1 features Dr Terry Dubrow on peptides, GLP-1s, longevity, regulation and why he believes this field could chang ...

Phil Micans: What does Putin know about peptides?

What did the Soviets discover about peptides?  Soviet researchers were studying peptide bioregulators decades before today’s longevity boom. Their work helped reshape Phil Micans’ thinking about food, gene activity and aging.  A co-founder of International Antiaging Systems and editor of Aging M ...

Michael Blyumin: Can you trust compounded GLP-1s?

Are you getting the GLP-1 you were expecting? The promise of weight loss can make starting a GLP-1 sound straightforward. Michael Blyumin wants patients to understand what they’re taking, what they can realistically expect, and what happens when they stop. A clinical pharmacist at Stanford Healt ...

Dr Chris Raynor: Why don't athletes take peptides?

Can peptides help athletes recover faster from injury?  When an injury keeps you out of training, the promise of a quicker recovery is hard to ignore. Some of Dr Chris Raynor’s patients are already using peptides by the time they see him. Some even believe a peptide injection reattached a torn t ...